Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.87127036 |
2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.87127036 |
3 | modulation by symbiont of host immune response (GO:0052553) | 4.87127036 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.87127036 |
5 | modulation by symbiont of host defense response (GO:0052031) | 4.87127036 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.87127036 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.83725409 |
8 | neutrophil activation involved in immune response (GO:0002283) | 4.58703858 |
9 | response to peptidoglycan (GO:0032494) | 4.29940374 |
10 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.92200258 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 3.88548018 |
12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.79030487 |
13 | macrophage activation involved in immune response (GO:0002281) | 3.72805326 |
14 | regulation of interferon-alpha production (GO:0032647) | 3.67068013 |
15 | immunoglobulin mediated immune response (GO:0016064) | 3.62229947 |
16 | regulation of vitamin metabolic process (GO:0030656) | 3.55986131 |
17 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.53771993 |
18 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.51603843 |
19 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.41404936 |
20 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.33465280 |
21 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.32697107 |
22 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.31202116 |
23 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.27281175 |
24 | response to host immune response (GO:0052572) | 3.19329599 |
25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.19329599 |
26 | granulocyte activation (GO:0036230) | 3.16727082 |
27 | microglial cell activation (GO:0001774) | 3.16576468 |
28 | positive regulation of extracellular matrix organization (GO:1903055) | 3.15630011 |
29 | regulation of chemokine biosynthetic process (GO:0045073) | 3.11347974 |
30 | neutrophil activation (GO:0042119) | 3.10008304 |
31 | response to muramyl dipeptide (GO:0032495) | 3.05051540 |
32 | respiratory burst (GO:0045730) | 3.03470434 |
33 | detection of molecule of bacterial origin (GO:0032490) | 3.00454631 |
34 | response to host (GO:0075136) | 2.97255247 |
35 | response to host defenses (GO:0052200) | 2.97255247 |
36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.97255247 |
37 | reactive oxygen species biosynthetic process (GO:1903409) | 2.96486369 |
38 | negative regulation of lipid storage (GO:0010888) | 2.95857760 |
39 | positive regulation of interferon-beta production (GO:0032728) | 2.93488302 |
40 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.91166851 |
41 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.90045989 |
42 | natural killer cell mediated immunity (GO:0002228) | 2.90045989 |
43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.89235685 |
44 | regulation of cholesterol storage (GO:0010885) | 2.87620922 |
45 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.86820887 |
46 | response to interferon-alpha (GO:0035455) | 2.83989144 |
47 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.83339586 |
48 | T-helper 1 type immune response (GO:0042088) | 2.81952197 |
49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81012064 |
50 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.79944287 |
51 | macrophage activation (GO:0042116) | 2.79159038 |
52 | germinal center formation (GO:0002467) | 2.78626817 |
53 | cell adhesion mediated by integrin (GO:0033627) | 2.78081588 |
54 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.77495736 |
55 | skin morphogenesis (GO:0043589) | 2.77280939 |
56 | B cell mediated immunity (GO:0019724) | 2.75819619 |
57 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72612720 |
58 | response to type I interferon (GO:0034340) | 2.72271095 |
59 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.71162940 |
60 | cellular response to type I interferon (GO:0071357) | 2.70036465 |
61 | type I interferon signaling pathway (GO:0060337) | 2.70036465 |
62 | response to interferon-beta (GO:0035456) | 2.69797353 |
63 | hypotonic response (GO:0006971) | 2.69023179 |
64 | low-density lipoprotein particle clearance (GO:0034383) | 2.68436353 |
65 | myeloid cell activation involved in immune response (GO:0002275) | 2.67964567 |
66 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.67369968 |
67 | regulation of mononuclear cell migration (GO:0071675) | 2.67108146 |
68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.64849416 |
69 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.64849416 |
70 | cytokine secretion (GO:0050663) | 2.62870750 |
71 | superoxide anion generation (GO:0042554) | 2.62765516 |
72 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62088427 |
73 | positive regulation of type 2 immune response (GO:0002830) | 2.61839847 |
74 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.61611326 |
75 | I-kappaB phosphorylation (GO:0007252) | 2.61492161 |
76 | positive regulation of heat generation (GO:0031652) | 2.60477246 |
77 | positive regulation of chemokine production (GO:0032722) | 2.58927440 |
78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.57851635 |
79 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.57623573 |
80 | regulation of podosome assembly (GO:0071801) | 2.57438495 |
81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55803053 |
82 | glycosphingolipid catabolic process (GO:0046479) | 2.55084308 |
83 | response to thyroid hormone (GO:0097066) | 2.53727008 |
84 | leukocyte aggregation (GO:0070486) | 2.53441759 |
85 | regulation of macrophage chemotaxis (GO:0010758) | 2.52679821 |
86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51606443 |
87 | leukocyte mediated cytotoxicity (GO:0001909) | 2.49978929 |
88 | NIK/NF-kappaB signaling (GO:0038061) | 2.49965529 |
89 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.49735561 |
90 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.49453128 |
91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.47896254 |
92 | wound healing, spreading of epidermal cells (GO:0035313) | 2.47879644 |
93 | negative regulation of complement activation (GO:0045916) | 2.47313864 |
94 | adhesion of symbiont to host cell (GO:0044650) | 2.46590481 |
95 | virion attachment to host cell (GO:0019062) | 2.46590481 |
96 | pinocytosis (GO:0006907) | 2.46436148 |
97 | negative regulation of humoral immune response (GO:0002921) | 2.46204239 |
98 | oligosaccharide catabolic process (GO:0009313) | 2.45730477 |
99 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.45514614 |
100 | positive regulation of interleukin-6 production (GO:0032755) | 2.45356801 |
101 | defense response to protozoan (GO:0042832) | 2.44743819 |
102 | negative regulation of interleukin-12 production (GO:0032695) | 2.44440120 |
103 | regulation of fever generation (GO:0031620) | 2.44382544 |
104 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.42666517 |
105 | response to protozoan (GO:0001562) | 2.42583713 |
106 | cellular extravasation (GO:0045123) | 2.42550296 |
107 | regulation of mast cell degranulation (GO:0043304) | 2.42545615 |
108 | monocyte chemotaxis (GO:0002548) | 2.41568659 |
109 | cellular response to virus (GO:0098586) | 2.41436512 |
110 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.40997951 |
111 | apoptotic cell clearance (GO:0043277) | 2.40488037 |
112 | detection of external biotic stimulus (GO:0098581) | 2.39291960 |
113 | positive regulation of antigen processing and presentation (GO:0002579) | 2.39269866 |
114 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.38789593 |
115 | cellular response to exogenous dsRNA (GO:0071360) | 2.37942807 |
116 | cellular response to interferon-alpha (GO:0035457) | 2.36362357 |
117 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.35105657 |
118 | glycolipid catabolic process (GO:0019377) | 2.34942833 |
119 | neutrophil mediated immunity (GO:0002446) | 2.33721461 |
120 | cellular response to interferon-beta (GO:0035458) | 2.33141059 |
121 | positive regulation of interleukin-12 production (GO:0032735) | 2.32577432 |
122 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.32225175 |
123 | negative regulation of protein activation cascade (GO:2000258) | 2.30676991 |
124 | desmosome organization (GO:0002934) | 2.30599409 |
125 | peptide catabolic process (GO:0043171) | 2.30549317 |
126 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.30470017 |
127 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.30273216 |
128 | myeloid dendritic cell differentiation (GO:0043011) | 2.29878374 |
129 | protein localization to endosome (GO:0036010) | 2.29722343 |
130 | positive regulation of leukocyte degranulation (GO:0043302) | 2.29474550 |
131 | adhesion of symbiont to host (GO:0044406) | 2.29339578 |
132 | regulation of chronic inflammatory response (GO:0002676) | 2.28951100 |
133 | cellular response to lipopolysaccharide (GO:0071222) | 2.27689232 |
134 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.24999584 |
135 | cellular response to ethanol (GO:0071361) | 2.23232081 |
136 | regulation of type 2 immune response (GO:0002828) | 2.23178948 |
137 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.22831819 |
138 | iron ion import (GO:0097286) | 2.22279521 |
139 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.21952860 |
140 | detection of other organism (GO:0098543) | 2.21377285 |
141 | positive regulation of natural killer cell activation (GO:0032816) | 2.17416157 |
142 | decidualization (GO:0046697) | 2.16465661 |
143 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.15061176 |
144 | negative regulation of interleukin-17 production (GO:0032700) | 2.14850654 |
145 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.13927931 |
146 | positive regulation of acute inflammatory response (GO:0002675) | 2.12608131 |
147 | keratan sulfate catabolic process (GO:0042340) | 2.12410887 |
148 | surfactant homeostasis (GO:0043129) | 2.11921939 |
149 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.11635528 |
150 | regulation of tolerance induction (GO:0002643) | 2.11053474 |
151 | barbed-end actin filament capping (GO:0051016) | 2.10210669 |
152 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.10053353 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.01193787 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.75477294 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.56577360 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.35474328 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.25884822 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.14187462 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09609746 |
8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96892238 |
9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.89641053 |
10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.88205072 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.79752702 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.73329376 |
13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.68295537 |
14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.68180193 |
15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60591599 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60093407 |
17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.58743819 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45146813 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44078334 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.24763334 |
21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.24378942 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18486685 |
23 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07995015 |
24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06818928 |
25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03944025 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00600366 |
27 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.99531171 |
28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98390798 |
29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94379709 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92860778 |
31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86776204 |
32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81940753 |
33 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81108607 |
34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.76628354 |
35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.70960843 |
36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.68086149 |
37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58254657 |
38 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57751874 |
39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51706526 |
40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51130704 |
41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48676487 |
42 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47654199 |
43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46345535 |
44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44399205 |
45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40233263 |
46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38531789 |
47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37065551 |
48 | * MYB_26560356_Chip-Seq_TH2_Human | 1.36343080 |
49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36164415 |
50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35834051 |
51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34034055 |
52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32954520 |
53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32469056 |
54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32118600 |
55 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.31567355 |
56 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.31567355 |
57 | MAF_26560356_Chip-Seq_TH1_Human | 1.29493542 |
58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27962735 |
59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27097727 |
60 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26710055 |
61 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25834616 |
62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25595774 |
63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25488159 |
64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25373495 |
65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23257397 |
66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22224459 |
67 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20785626 |
68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19725992 |
69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18443898 |
70 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18028397 |
71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17644406 |
72 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17223112 |
73 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.13986991 |
74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13454994 |
75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12531348 |
76 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12408889 |
77 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12347034 |
78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12093378 |
79 | MYB_26560356_Chip-Seq_TH1_Human | 1.11952926 |
80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11182264 |
81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10211886 |
82 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10155169 |
83 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.09020548 |
84 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.07063192 |
85 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06797699 |
86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06630155 |
87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06446155 |
88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05953030 |
89 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05035656 |
90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05011793 |
91 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04628214 |
92 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04573428 |
93 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04238742 |
94 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03670204 |
95 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03607010 |
96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03308462 |
97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02649224 |
98 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01506358 |
99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01293311 |
100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00793067 |
101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00770734 |
102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00733750 |
103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00525156 |
104 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98842169 |
105 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98842169 |
106 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.98836278 |
107 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98028286 |
108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97902346 |
109 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97591951 |
110 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95224536 |
111 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95032890 |
112 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94737630 |
113 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92611114 |
114 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.92288071 |
115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92116092 |
116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91806148 |
117 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91001140 |
118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90795002 |
119 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90783739 |
120 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89607387 |
121 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88624777 |
122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88546963 |
123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88145269 |
124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87748583 |
125 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87687079 |
126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87442408 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.16361311 |
2 | MP0009785_altered_susceptibility_to | 3.09200088 |
3 | MP0003436_decreased_susceptibility_to | 3.03192655 |
4 | MP0003724_increased_susceptibility_to | 2.84372911 |
5 | MP0002148_abnormal_hypersensitivity_rea | 2.53512906 |
6 | * MP0002419_abnormal_innate_immunity | 2.41808912 |
7 | MP0006082_CNS_inflammation | 2.41342930 |
8 | MP0005058_abnormal_lysosome_morphology | 2.39258472 |
9 | MP0005025_abnormal_response_to | 2.24627418 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.18026119 |
11 | MP0003303_peritoneal_inflammation | 2.16656617 |
12 | * MP0005000_abnormal_immune_tolerance | 2.13809539 |
13 | MP0009840_abnormal_foam_cell | 2.07412236 |
14 | MP0005451_abnormal_body_composition | 1.93734926 |
15 | * MP0002452_abnormal_antigen_presenting | 1.87751444 |
16 | MP0009764_decreased_sensitivity_to | 1.87584520 |
17 | MP0000685_abnormal_immune_system | 1.86976596 |
18 | MP0001853_heart_inflammation | 1.86046121 |
19 | MP0005387_immune_system_phenotype | 1.81007666 |
20 | MP0001790_abnormal_immune_system | 1.81007666 |
21 | MP0004947_skin_inflammation | 1.80288167 |
22 | MP0001533_abnormal_skeleton_physiology | 1.78175228 |
23 | MP0003300_gastrointestinal_ulcer | 1.77222820 |
24 | MP0005464_abnormal_platelet_physiology | 1.76657052 |
25 | MP0000343_altered_response_to | 1.73320186 |
26 | * MP0002723_abnormal_immune_serum | 1.70034688 |
27 | MP0010234_abnormal_vibrissa_follicle | 1.69214602 |
28 | * MP0001800_abnormal_humoral_immune | 1.66340796 |
29 | MP0003950_abnormal_plasma_membrane | 1.61869031 |
30 | * MP0001845_abnormal_inflammatory_respons | 1.55396033 |
31 | MP0002877_abnormal_melanocyte_morpholog | 1.55264336 |
32 | * MP0010155_abnormal_intestine_physiology | 1.54787856 |
33 | MP0005671_abnormal_response_to | 1.53016326 |
34 | MP0008438_abnormal_cutaneous_collagen | 1.52655198 |
35 | * MP0001819_abnormal_immune_cell | 1.51426090 |
36 | MP0004782_abnormal_surfactant_physiolog | 1.51342272 |
37 | MP0006054_spinal_hemorrhage | 1.51143614 |
38 | * MP0002420_abnormal_adaptive_immunity | 1.49126605 |
39 | MP0003448_altered_tumor_morphology | 1.49060186 |
40 | MP0003705_abnormal_hypodermis_morpholog | 1.48599386 |
41 | MP0005167_abnormal_blood-brain_barrier | 1.47891310 |
42 | * MP0008469_abnormal_protein_level | 1.46721842 |
43 | MP0010352_gastrointestinal_tract_polyps | 1.46671717 |
44 | * MP0002405_respiratory_system_inflammati | 1.46132976 |
45 | MP0002139_abnormal_hepatobiliary_system | 1.44756367 |
46 | MP0002006_tumorigenesis | 1.44146430 |
47 | MP0009278_abnormal_bone_marrow | 1.44126353 |
48 | * MP0003186_abnormal_redox_activity | 1.43073582 |
49 | MP0000858_altered_metastatic_potential | 1.42672090 |
50 | * MP0003656_abnormal_erythrocyte_physiolo | 1.39197351 |
51 | MP0003806_abnormal_nucleotide_metabolis | 1.38787556 |
52 | MP0005397_hematopoietic_system_phenotyp | 1.38150333 |
53 | MP0001545_abnormal_hematopoietic_system | 1.38150333 |
54 | MP0005360_urolithiasis | 1.37688162 |
55 | MP0002138_abnormal_hepatobiliary_system | 1.35384154 |
56 | MP0002254_reproductive_system_inflammat | 1.35232939 |
57 | MP0003566_abnormal_cell_adhesion | 1.33415050 |
58 | MP0000465_gastrointestinal_hemorrhage | 1.27985161 |
59 | MP0005023_abnormal_wound_healing | 1.27162811 |
60 | MP0001958_emphysema | 1.26849566 |
61 | MP0003828_pulmonary_edema | 1.26148185 |
62 | MP0004510_myositis | 1.25140094 |
63 | MP0008004_abnormal_stomach_pH | 1.22811174 |
64 | MP0003453_abnormal_keratinocyte_physiol | 1.22577074 |
65 | MP0003195_calcinosis | 1.22532807 |
66 | MP0002166_altered_tumor_susceptibility | 1.19262340 |
67 | MP0002998_abnormal_bone_remodeling | 1.18002065 |
68 | MP0005164_abnormal_response_to | 1.16780623 |
69 | MP0005166_decreased_susceptibility_to | 1.16493890 |
70 | MP0003252_abnormal_bile_duct | 1.09441496 |
71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.08350950 |
72 | MP0003172_abnormal_lysosome_physiology | 1.08171873 |
73 | * MP0003075_altered_response_to | 1.07833810 |
74 | MP0005083_abnormal_biliary_tract | 1.05524712 |
75 | MP0001542_abnormal_bone_strength | 1.05335039 |
76 | * MP0000716_abnormal_immune_system | 1.05242326 |
77 | MP0002060_abnormal_skin_morphology | 1.04161268 |
78 | MP0003279_aneurysm | 1.02926631 |
79 | MP0001216_abnormal_epidermal_layer | 1.00021390 |
80 | MP0002796_impaired_skin_barrier | 0.99206847 |
81 | * MP0009333_abnormal_splenocyte_physiolog | 0.98848277 |
82 | * MP0009763_increased_sensitivity_to | 0.98836028 |
83 | MP0005390_skeleton_phenotype | 0.97770407 |
84 | MP0000249_abnormal_blood_vessel | 0.94819914 |
85 | MP0005076_abnormal_cell_differentiation | 0.93756402 |
86 | * MP0002398_abnormal_bone_marrow | 0.93243808 |
87 | MP0010307_abnormal_tumor_latency | 0.92514244 |
88 | MP0005085_abnormal_gallbladder_physiolo | 0.92383413 |
89 | MP0003183_abnormal_peptide_metabolism | 0.92066593 |
90 | MP0000490_abnormal_crypts_of | 0.91884714 |
91 | * MP0000609_abnormal_liver_physiology | 0.90848502 |
92 | MP0002933_joint_inflammation | 0.90126555 |
93 | MP0002896_abnormal_bone_mineralization | 0.89814651 |
94 | * MP0002429_abnormal_blood_cell | 0.89741291 |
95 | MP0008260_abnormal_autophagy | 0.89396409 |
96 | MP0003795_abnormal_bone_structure | 0.89363171 |
97 | * MP0005165_increased_susceptibility_to | 0.89165146 |
98 | MP0005365_abnormal_bile_salt | 0.88634804 |
99 | MP0005310_abnormal_salivary_gland | 0.88633212 |
100 | MP0010678_abnormal_skin_adnexa | 0.88544570 |
101 | MP0002332_abnormal_exercise_endurance | 0.88512894 |
102 | * MP0000689_abnormal_spleen_morphology | 0.88386171 |
103 | MP0005257_abnormal_intraocular_pressure | 0.86683779 |
104 | MP0003045_fibrosis | 0.86356606 |
105 | MP0000604_amyloidosis | 0.85962667 |
106 | MP0005275_abnormal_skin_tensile | 0.84794402 |
107 | MP0001873_stomach_inflammation | 0.84161271 |
108 | * MP0002136_abnormal_kidney_physiology | 0.83488761 |
109 | MP0003690_abnormal_glial_cell | 0.83218284 |
110 | MP0002168_other_aberrant_phenotype | 0.82052338 |
111 | MP0001666_abnormal_nutrient_absorption | 0.82018321 |
112 | MP0000920_abnormal_myelination | 0.81626935 |
113 | MP0004883_abnormal_blood_vessel | 0.81079176 |
114 | * MP0002722_abnormal_immune_system | 0.81029443 |
115 | * MP0005319_abnormal_enzyme/_coenzyme | 0.80947189 |
116 | MP0000767_abnormal_smooth_muscle | 0.80199623 |
117 | MP0010368_abnormal_lymphatic_system | 0.79968308 |
118 | MP0001851_eye_inflammation | 0.79439784 |
119 | MP0004272_abnormal_basement_membrane | 0.78023094 |
120 | MP0003091_abnormal_cell_migration | 0.77587221 |
121 | * MP0009643_abnormal_urine_homeostasis | 0.76370076 |
122 | MP0002132_abnormal_respiratory_system | 0.76274721 |
123 | MP0000371_diluted_coat_color | 0.75636157 |
124 | MP0003763_abnormal_thymus_physiology | 0.74547600 |
125 | MP0010329_abnormal_lipoprotein_level | 0.73773101 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.75188783 |
2 | Eczematoid dermatitis (HP:0000976) | 5.56687672 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.26422258 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.82617232 |
5 | Abnormality of macrophages (HP:0004311) | 4.14633319 |
6 | Systemic lupus erythematosus (HP:0002725) | 3.98524876 |
7 | Vacuolated lymphocytes (HP:0001922) | 3.94287129 |
8 | Interstitial pulmonary disease (HP:0006530) | 3.86952284 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.81157949 |
10 | Autoimmune thrombocytopenia (HP:0001973) | 3.77766509 |
11 | Mediastinal lymphadenopathy (HP:0100721) | 3.62916704 |
12 | Gingivitis (HP:0000230) | 3.44874647 |
13 | Orchitis (HP:0100796) | 3.44015939 |
14 | Myositis (HP:0100614) | 3.39406043 |
15 | Increased cerebral lipofuscin (HP:0011813) | 3.38225633 |
16 | Pustule (HP:0200039) | 3.35125136 |
17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.28699091 |
18 | Recurrent skin infections (HP:0001581) | 3.14283918 |
19 | Axonal loss (HP:0003447) | 3.14211580 |
20 | Stomatitis (HP:0010280) | 3.00265688 |
21 | Osteolytic defects of the hand bones (HP:0009699) | 2.93962389 |
22 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.93962389 |
23 | Myocardial infarction (HP:0001658) | 2.91457230 |
24 | Periodontitis (HP:0000704) | 2.90782638 |
25 | Glomerulonephritis (HP:0000099) | 2.89065094 |
26 | Spondylolisthesis (HP:0003302) | 2.82564928 |
27 | Thick nail (HP:0001805) | 2.81436146 |
28 | Retrobulbar optic neuritis (HP:0100654) | 2.79989323 |
29 | Optic neuritis (HP:0100653) | 2.79989323 |
30 | Hematochezia (HP:0002573) | 2.76696892 |
31 | Recurrent fungal infections (HP:0002841) | 2.73621821 |
32 | Protrusio acetabuli (HP:0003179) | 2.66208828 |
33 | Esophageal varix (HP:0002040) | 2.62431838 |
34 | Vasculitis (HP:0002633) | 2.57319144 |
35 | Urticaria (HP:0001025) | 2.54401569 |
36 | Dysostosis multiplex (HP:0000943) | 2.53796519 |
37 | Nephritis (HP:0000123) | 2.51528412 |
38 | Nausea (HP:0002018) | 2.48982361 |
39 | Tetraparesis (HP:0002273) | 2.48678127 |
40 | Vascular tortuosity (HP:0004948) | 2.40563742 |
41 | Basal ganglia calcification (HP:0002135) | 2.39795027 |
42 | Alopecia of scalp (HP:0002293) | 2.36653903 |
43 | Arterial tortuosity (HP:0005116) | 2.35069174 |
44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35021993 |
45 | Mucopolysacchariduria (HP:0008155) | 2.35021993 |
46 | Neurofibrillary tangles (HP:0002185) | 2.33793634 |
47 | Cellulitis (HP:0100658) | 2.30368263 |
48 | Osteomyelitis (HP:0002754) | 2.29477980 |
49 | Recurrent viral infections (HP:0004429) | 2.28130680 |
50 | Peritonitis (HP:0002586) | 2.26101500 |
51 | Aortic aneurysm (HP:0004942) | 2.26049802 |
52 | Nuclear cataract (HP:0100018) | 2.24809960 |
53 | Gingival bleeding (HP:0000225) | 2.24777280 |
54 | Disinhibition (HP:0000734) | 2.24461723 |
55 | Abnormality of complement system (HP:0005339) | 2.19247444 |
56 | Prostate neoplasm (HP:0100787) | 2.19171590 |
57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18710955 |
58 | Obstructive lung disease (HP:0006536) | 2.18710955 |
59 | Purpura (HP:0000979) | 2.18092580 |
60 | Abnormality of the nasal mucosa (HP:0000433) | 2.17896412 |
61 | Increased CSF protein (HP:0002922) | 2.16496301 |
62 | Vertebral compression fractures (HP:0002953) | 2.15745513 |
63 | Joint hemorrhage (HP:0005261) | 2.14859244 |
64 | Hepatosplenomegaly (HP:0001433) | 2.13035811 |
65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13003356 |
66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13003356 |
67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13003356 |
68 | Complement deficiency (HP:0004431) | 2.12850223 |
69 | Anorexia (HP:0002039) | 2.11186603 |
70 | Petechiae (HP:0000967) | 2.10878661 |
71 | Gangrene (HP:0100758) | 2.10134381 |
72 | Malnutrition (HP:0004395) | 2.09658737 |
73 | Increased serum ferritin (HP:0003281) | 2.09400102 |
74 | Gastrointestinal infarctions (HP:0005244) | 2.08996430 |
75 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08100408 |
76 | Aortic dissection (HP:0002647) | 2.07897736 |
77 | Arterial thrombosis (HP:0004420) | 2.07822298 |
78 | Spontaneous hematomas (HP:0007420) | 2.07814428 |
79 | Pulmonary infiltrates (HP:0002113) | 2.05138274 |
80 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04838044 |
81 | Amyloidosis (HP:0011034) | 2.00364846 |
82 | Deep venous thrombosis (HP:0002625) | 2.00283877 |
83 | Increased IgE level (HP:0003212) | 1.99993749 |
84 | Mitral stenosis (HP:0001718) | 1.99482444 |
85 | Leukocytosis (HP:0001974) | 1.98489067 |
86 | Abnormality of proline metabolism (HP:0010907) | 1.97352387 |
87 | Hydroxyprolinuria (HP:0003080) | 1.97352387 |
88 | Nasal polyposis (HP:0100582) | 1.97145095 |
89 | Abnormality of iron homeostasis (HP:0011031) | 1.93324688 |
90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92827133 |
91 | Cervical subluxation (HP:0003308) | 1.92326867 |
92 | Bone pain (HP:0002653) | 1.90641589 |
93 | Premature loss of primary teeth (HP:0006323) | 1.90314689 |
94 | Asymmetric septal hypertrophy (HP:0001670) | 1.89436054 |
95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.87559781 |
96 | Hemoptysis (HP:0002105) | 1.87515578 |
97 | Coarse hair (HP:0002208) | 1.87032923 |
98 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.85421092 |
99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85232335 |
100 | Xanthomatosis (HP:0000991) | 1.84255277 |
101 | Skin ulcer (HP:0200042) | 1.82791927 |
102 | Keratoconjunctivitis (HP:0001096) | 1.80217049 |
103 | Epistaxis (HP:0000421) | 1.79460448 |
104 | Aneurysm (HP:0002617) | 1.79204242 |
105 | Metaphyseal irregularity (HP:0003025) | 1.79110005 |
106 | Pathologic fracture (HP:0002756) | 1.79071118 |
107 | Loss of speech (HP:0002371) | 1.78074560 |
108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77026913 |
109 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77026913 |
110 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77026913 |
111 | Recurrent pneumonia (HP:0006532) | 1.75711174 |
112 | Keratoconjunctivitis sicca (HP:0001097) | 1.75295035 |
113 | Premature rupture of membranes (HP:0001788) | 1.74409395 |
114 | Abnormality of the pericardium (HP:0001697) | 1.74377563 |
115 | Absent frontal sinuses (HP:0002688) | 1.73919585 |
116 | Polycythemia (HP:0001901) | 1.73762507 |
117 | Follicular hyperkeratosis (HP:0007502) | 1.73459019 |
118 | Agnosia (HP:0010524) | 1.72678344 |
119 | Cerebral inclusion bodies (HP:0100314) | 1.71113609 |
120 | Autoimmune hemolytic anemia (HP:0001890) | 1.70959232 |
121 | Micronodular cirrhosis (HP:0001413) | 1.70591304 |
122 | Increased IgM level (HP:0003496) | 1.70291699 |
123 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.68867807 |
124 | Recurrent cutaneous fungal infections (HP:0011370) | 1.68867807 |
125 | Steatorrhea (HP:0002570) | 1.68564432 |
126 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.67956343 |
127 | Cardiovascular calcification (HP:0011915) | 1.67496996 |
128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67360224 |
129 | Fat malabsorption (HP:0002630) | 1.67116180 |
130 | Abnormality of the common coagulation pathway (HP:0010990) | 1.66684874 |
131 | Cerebral aneurysm (HP:0004944) | 1.66446725 |
132 | Ovoid vertebral bodies (HP:0003300) | 1.66097859 |
133 | Colitis (HP:0002583) | 1.65827871 |
134 | Flat acetabular roof (HP:0003180) | 1.64894735 |
135 | Hemorrhage of the eye (HP:0011885) | 1.64421236 |
136 | Poor head control (HP:0002421) | 1.63841723 |
137 | Diaphragmatic weakness (HP:0009113) | 1.63707630 |
138 | Vascular calcification (HP:0004934) | 1.62935614 |
139 | Dilatation of the ascending aorta (HP:0005111) | 1.61812817 |
140 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.60713557 |
141 | Progressive neurologic deterioration (HP:0002344) | 1.59578497 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 3.32074246 |
2 | IRAK3 | 2.95053063 |
3 | TBK1 | 2.91661573 |
4 | ERN1 | 2.84976175 |
5 | DDR2 | 2.51709713 |
6 | BLK | 2.45704872 |
7 | TYK2 | 2.45622921 |
8 | TGFBR2 | 2.32978330 |
9 | PIM2 | 2.29741292 |
10 | IRAK4 | 2.17883199 |
11 | PBK | 2.12791071 |
12 | IKBKE | 2.12020188 |
13 | IKBKB | 2.04697907 |
14 | RIPK1 | 2.02566591 |
15 | RIPK4 | 2.01337451 |
16 | NEK9 | 1.97847172 |
17 | GRK7 | 1.95892622 |
18 | BMPR2 | 1.89189283 |
19 | MAP4K1 | 1.85738741 |
20 | MST4 | 1.82378316 |
21 | JAK3 | 1.75271875 |
22 | STK10 | 1.74762033 |
23 | RPS6KA4 | 1.73217678 |
24 | PRPF4B | 1.69572145 |
25 | EPHA2 | 1.59322448 |
26 | EPHB1 | 1.56986763 |
27 | MAP3K3 | 1.56608541 |
28 | KIT | 1.56547511 |
29 | MAP3K2 | 1.55635725 |
30 | PDGFRA | 1.54346133 |
31 | TAOK2 | 1.53871427 |
32 | ZAP70 | 1.53011216 |
33 | TXK | 1.50727103 |
34 | CHUK | 1.49509799 |
35 | NME2 | 1.47808651 |
36 | JAK1 | 1.46138850 |
37 | CSK | 1.45608663 |
38 | CDC42BPA | 1.44482684 |
39 | AKT3 | 1.43010990 |
40 | MST1R | 1.38049353 |
41 | SIK3 | 1.31900525 |
42 | MAP2K3 | 1.30865419 |
43 | LRRK2 | 1.26605674 |
44 | MAP3K13 | 1.20008518 |
45 | MAP3K1 | 1.18322241 |
46 | MATK | 1.18276506 |
47 | FGFR4 | 1.17709380 |
48 | TRIB3 | 1.16725014 |
49 | PAK4 | 1.13905228 |
50 | PTK6 | 1.13520575 |
51 | TTN | 1.13124451 |
52 | PIM1 | 1.11219112 |
53 | TAOK3 | 1.05890814 |
54 | TEC | 1.04876348 |
55 | TRPM7 | 1.03024420 |
56 | CSF1R | 1.02262726 |
57 | CDK6 | 1.00413085 |
58 | STK3 | 1.00260809 |
59 | BMX | 0.99266399 |
60 | FER | 0.92373933 |
61 | TAOK1 | 0.91464077 |
62 | BTK | 0.91355535 |
63 | FLT3 | 0.90514372 |
64 | MAP3K12 | 0.88323834 |
65 | MAP2K2 | 0.87756874 |
66 | ABL2 | 0.87571005 |
67 | PKN2 | 0.85852635 |
68 | JAK2 | 0.84702750 |
69 | NUAK1 | 0.84412133 |
70 | MAP3K10 | 0.83432143 |
71 | FRK | 0.83388926 |
72 | STK4 | 0.82972897 |
73 | KDR | 0.81772929 |
74 | LYN | 0.80884563 |
75 | SIK1 | 0.78711279 |
76 | HCK | 0.76397793 |
77 | MAPKAPK3 | 0.75159027 |
78 | EPHA3 | 0.74410594 |
79 | TGFBR1 | 0.71844933 |
80 | PRKG2 | 0.70627290 |
81 | TESK1 | 0.67479004 |
82 | LCK | 0.66581144 |
83 | FGFR3 | 0.65610273 |
84 | MAP3K6 | 0.64747758 |
85 | DMPK | 0.63751632 |
86 | STK24 | 0.63124755 |
87 | MET | 0.63041884 |
88 | MAPK7 | 0.62354670 |
89 | MELK | 0.61850863 |
90 | MOS | 0.61209820 |
91 | LMTK2 | 0.60368894 |
92 | EGFR | 0.59324645 |
93 | EIF2AK2 | 0.59161455 |
94 | ABL1 | 0.58968781 |
95 | LATS1 | 0.58768723 |
96 | LATS2 | 0.58543399 |
97 | SGK3 | 0.58102875 |
98 | ERBB4 | 0.57451377 |
99 | PIK3CG | 0.57317561 |
100 | CDK12 | 0.56122168 |
101 | SYK | 0.55349214 |
102 | PDK2 | 0.54499552 |
103 | PDPK1 | 0.54356875 |
104 | FGR | 0.53379601 |
105 | NEK6 | 0.53219178 |
106 | MAP3K11 | 0.52899088 |
107 | MAPKAPK2 | 0.52770520 |
108 | CAMK1D | 0.52721547 |
109 | ITK | 0.52037506 |
110 | TIE1 | 0.51867730 |
111 | MARK3 | 0.51637447 |
112 | ACVR1B | 0.51614030 |
113 | PRKAA2 | 0.50048549 |
114 | MAP3K8 | 0.47840736 |
115 | CDK9 | 0.47809250 |
116 | MAP3K5 | 0.47582717 |
117 | NLK | 0.47489946 |
118 | * PRKCD | 0.47276832 |
119 | HIPK2 | 0.47120391 |
120 | PDGFRB | 0.46905428 |
121 | GRK6 | 0.46645021 |
122 | STK38 | 0.46334702 |
123 | DYRK1B | 0.42769761 |
124 | MAPK11 | 0.42734425 |
125 | GSK3A | 0.42636907 |
126 | MAP3K7 | 0.41467250 |
127 | ERBB3 | 0.41429874 |
128 | ZAK | 0.40893542 |
129 | PTK2 | 0.40542514 |
130 | ADRBK2 | 0.39669263 |
131 | MYLK | 0.39314393 |
132 | EIF2AK3 | 0.37993469 |
133 | RPS6KB2 | 0.35220326 |
134 | RPS6KA6 | 0.35004136 |
135 | IRAK1 | 0.31377539 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.04401840 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89752072 |
3 | Legionellosis_Homo sapiens_hsa05134 | 2.53121851 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40826342 |
5 | Malaria_Homo sapiens_hsa05144 | 2.35968253 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.33617722 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.23182810 |
8 | Pertussis_Homo sapiens_hsa05133 | 2.06900459 |
9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99846904 |
10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.92386320 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.83796821 |
12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82611199 |
13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74363024 |
14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73718345 |
15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.72908948 |
16 | Tuberculosis_Homo sapiens_hsa05152 | 1.72373807 |
17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.70528794 |
18 | Lysosome_Homo sapiens_hsa04142 | 1.66047283 |
19 | Measles_Homo sapiens_hsa05162 | 1.60432805 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 1.58608268 |
21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.56904014 |
22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53938641 |
23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.50949322 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.44747117 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43712241 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43507683 |
27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43147566 |
28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42176388 |
29 | Salmonella infection_Homo sapiens_hsa05132 | 1.37461406 |
30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.32453146 |
31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.30723633 |
32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28643611 |
33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.27867879 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27405937 |
35 | Apoptosis_Homo sapiens_hsa04210 | 1.25347109 |
36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22995646 |
37 | Asthma_Homo sapiens_hsa05310 | 1.22900276 |
38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20985494 |
39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20590558 |
40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18169196 |
41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17703059 |
42 | Phagosome_Homo sapiens_hsa04145 | 1.17608146 |
43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13936594 |
44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13563053 |
45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09116982 |
46 | Amoebiasis_Homo sapiens_hsa05146 | 1.06140573 |
47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02651781 |
48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99139311 |
49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98919656 |
50 | Shigellosis_Homo sapiens_hsa05131 | 0.97921059 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97778845 |
52 | Bladder cancer_Homo sapiens_hsa05219 | 0.96597149 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 0.96020112 |
54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93324276 |
55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92832525 |
56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92418584 |
57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84355607 |
58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83026423 |
59 | Hepatitis B_Homo sapiens_hsa05161 | 0.82868164 |
60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81215770 |
61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80934782 |
62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79664209 |
63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78263645 |
64 | Mineral absorption_Homo sapiens_hsa04978 | 0.75491163 |
65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75275885 |
66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75068268 |
67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71406034 |
68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70440396 |
69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66541732 |
70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64031366 |
71 | Peroxisome_Homo sapiens_hsa04146 | 0.63339112 |
72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63218093 |
73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63196872 |
74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62777883 |
75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61409019 |
76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61363751 |
77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60519136 |
78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59908109 |
79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59021584 |
80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55433833 |
81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55396491 |
82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55329301 |
83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54783302 |
84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54431704 |
85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53935044 |
86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53456241 |
87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53390649 |
88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52754795 |
89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52724038 |
90 | Focal adhesion_Homo sapiens_hsa04510 | 0.52482092 |
91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52164054 |
92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51256536 |
93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50784943 |
94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50185132 |
95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49925764 |
96 | Prostate cancer_Homo sapiens_hsa05215 | 0.49484020 |
97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49418552 |
98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49339938 |
99 | ABC transporters_Homo sapiens_hsa02010 | 0.48682799 |
100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48396501 |
101 | Endocytosis_Homo sapiens_hsa04144 | 0.48176622 |
102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47748295 |
103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47348712 |
104 | Prion diseases_Homo sapiens_hsa05020 | 0.47242303 |
105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47183423 |
106 | Adherens junction_Homo sapiens_hsa04520 | 0.46278477 |
107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44699253 |
108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44488986 |
109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44223050 |
110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44071265 |
111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43640972 |
112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43485817 |
113 | Platelet activation_Homo sapiens_hsa04611 | 0.43266999 |
114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42963561 |
115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42635386 |
116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42566196 |
117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42312391 |
118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40672823 |
119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39115726 |
120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38885189 |
121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38135778 |
122 | Insulin resistance_Homo sapiens_hsa04931 | 0.37308301 |
123 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37213232 |
124 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35505651 |
125 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34703619 |